Literature DB >> 14507313

Thyroid nodular lesion: analysis of cancer risk based on Kuma Hospital experience.

Ichiro Mori1, Akira Miyauchi, Seiji Kuma, Weihua Tang, Kennichi Kakudo.   

Abstract

It is a difficult question, whether it is malignant or not, when you follow up patients with thyroid nodular lesions. Cytological examination helps to solve this issue more accurately but a cancer risk still exists in patients with a negative cytology, non-diagnostic or suspicious follicular neoplasms. Analysis of cancer risk in patients with benign thyroid nodular lesions was carried out among 1044 cases who underwent thyroid surgery at Kuma Hospital, Kobe, Japan, in 2000. The purpose of this study was to provide evidence of cancer risk in those patients in Japan. Among the 356 cases with benign nodular lesions, 99 cases of papillary carcinoma were found in the thyroid parenchyma. Seventy-nine of the 99 cases were clinical cancer and were found preoperatively by cytology, while 20 out of 277 (7.22%) cases were found postoperatively as incidental carcinoma. The incidence of follicular carcinoma of a minimally invasive type in the index nodule was 22 out of 279 (7.89%) cases in patients who were surgically treated.

Entities:  

Mesh:

Year:  2003        PMID: 14507313     DOI: 10.1046/j.1440-1827.2003.01530.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

1.  Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

2.  Parathyroid invasion, nodal recurrence, and lung metastasis by papillary carcinoma of the thyroid.

Authors:  K Kakudo; W Tang; Y Ito; Y Nakamura; H Yasuoka; S Morita; A Miyauchi
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.